These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37043902)
1. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects. Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902 [TBL] [Abstract][Full Text] [Related]
2. Effect of direct-acting antivirals on the titers of human pegivirus 1 during treatment of chronic hepatitis C patients. Fahnøe U; Madsen LW; Christensen PB; Sølund CS; Mollerup S; Pinholt M; Weis N; Øvrehus A; Bukh J Microbiol Spectr; 2024 Sep; 12(9):e0064124. PubMed ID: 39051781 [TBL] [Abstract][Full Text] [Related]
3. RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature. Chen S; Wu J; Yang X; Sun Q; Liu S; Rashid F; Dzakah EE; Wang H; Wang J; Gong P; Tang S Microbiol Spectr; 2022 Oct; 10(5):e0272922. PubMed ID: 35980196 [TBL] [Abstract][Full Text] [Related]
4. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders. Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448 [TBL] [Abstract][Full Text] [Related]
5. Whole-genome sequencing of human Pegivirus variant from an Egyptian patient co-infected with hepatitis C virus: a case report. Soliman HK; Abouelhoda M; El Rouby MN; Ahmed OS; Esmat G; Hassan ZK; Hafez MM; Mehaney DA; Selvaraju M; Darwish RK; Osman YA; Zekri AN Virol J; 2019 Nov; 16(1):132. PubMed ID: 31711510 [TBL] [Abstract][Full Text] [Related]
6. A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection. Wang H; Wan Z; Xu R; Guan Y; Zhu N; Li J; Xie Z; Lu A; Zhang F; Fu Y; Tang S Clin Infect Dis; 2018 Jan; 66(1):29-35. PubMed ID: 29020289 [TBL] [Abstract][Full Text] [Related]
7. Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients. Liang Y; Hu F; Fan H; Li L; Wan Z; Wang H; Shui J; Zhou Y; Tong Y; Cai W; Tang S Front Cell Infect Microbiol; 2021; 11():728415. PubMed ID: 34466405 [TBL] [Abstract][Full Text] [Related]
8. A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY). Wilson E; Covert E; Hoffmann J; Comstock E; Emmanuel B; Tang L; Husson J; Chua J; Price A; Mathur P; Rosenthal E; Kattakuzhy S; Masur H; Kottilil S J Hepatol; 2019 Sep; 71(3):498-504. PubMed ID: 31173815 [TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection. Xiao H; Chen J; Wang J; Li J; Yang F; Lu H Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267 [TBL] [Abstract][Full Text] [Related]
10. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective. Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060 [TBL] [Abstract][Full Text] [Related]
11. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy. Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C and Human Pegivirus Coinfection in Patients with Chronic Hepatitis C from the Brazilian Amazon Region: Prevalence, Genotypes and Clinical Data. Nunes PF; da Cruz Coelho E; da Silva JR; da Silva Costa CC; Sampaio RMA; Frade PCR; Ponteira NA; da Cruz SS; Seabra AD; Carneiro DM; Burbano RMR; Martins LC Viruses; 2023 Sep; 15(9):. PubMed ID: 37766298 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study. Amele S; Peters L; Rodger A; Lundgren J; Rockstroh J; Matulionyte R; Leen C; Jabłonowska E; Østergaard L; Bhagani S; Sarcletti M; Clarke A; Falconer K; Wandeler G; Domingo P; Maltez F; Zaccarelli M; Chkhartisvili N; Szlavik J; Stephan C; Fonquernie L; Aho I; Mocroft A; J Acquir Immune Defic Syndr; 2021 Feb; 86(2):248-257. PubMed ID: 33079903 [TBL] [Abstract][Full Text] [Related]
14. Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication. Wan Z; Liu J; Hu F; Shui J; Li L; Wang H; Tang X; Hu C; Liang Y; Zhou Y; Cai W; Tang S Emerg Microbes Infect; 2020; 9(1):485-495. PubMed ID: 32100631 [TBL] [Abstract][Full Text] [Related]
15. Pre-existing, treatment-specific resistance-associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct-acting antivirals. Sølund C; Pedersen MS; Fahnøe U; Filskov J; Jenssen H; Weis N; Schønning K; Bukh J APMIS; 2023 Aug; 131(8):426-433. PubMed ID: 37355962 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574 [TBL] [Abstract][Full Text] [Related]
17. Human pegivirus (HPgV, GBV-C) RNA in volunteer blood donors from a public hemotherapy service in Northern Brazil. Silva ASN; Silva CP; Barata RR; da Silva PVR; Monteiro PDJ; Lamarão L; Burbano RMR; Nunes MRT; de Lima PDL Virol J; 2020 Oct; 17(1):153. PubMed ID: 33054824 [TBL] [Abstract][Full Text] [Related]
18. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections. Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505 [TBL] [Abstract][Full Text] [Related]
19. Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis. Köksal MO; Pirkl M; Sarsar K; Ilktaç M; Horemheb-Rubio G; Yaman M; Meşe S; Eraksoy H; Akgül B; Ağaçfidan A Viruses; 2023 Dec; 16(1):. PubMed ID: 38275941 [TBL] [Abstract][Full Text] [Related]
20. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]